[1]
|
Farr, R.S., Cox, C.P., Wardlow, M.L., et al. (1980) Preliminary Studies of an Acid-Labile Factor (ALF) in Human Sera That Inactivates Platelet-Activating Factor (PAF). Clinical Immunology & Immunopathology, 15, 318-330.
https://doi.org/10.1016/0090-1229(80)90044-6
|
[2]
|
Tew, D.G., Southan, C., Rice, S.Q.J., et al. (1996) Purification, Properties, Sequencing, and Cloning of a Lipoprotein-Associated, Serine-Dependent Phospholipase Involved in the Oxidative Modification of Low-Density Lipoproteins. Arteriosclerosis, Thrombosis, and Vascular Biology, 16, 591. https://doi.org/10.1161/01.ATV.16.4.591
|
[3]
|
Corson, M.A., Jones, P.H. and Davidson, M.H. (2008) Review of the Evidence for the Clinical Utility of Lipoprotein-Associated Phospholipase A2 as a Cardiovascular Risk Marker. American Journal of Cardiology, 101, S41-S50.
https://doi.org/10.1016/j.amjcard.2008.04.018
|
[4]
|
Lavi, S., McConnell, J.P., Rihal, C.S., et al. (2007) Local Production of Lipoprotein-Associated Phospholipase A2 and Lysophosphatidylcholine in the Coronary Circulation: Association with Early Coronary Atherosclerosis and Endothelial Dysfunction in Humans. Circulation, 115, 2715-2721.
https://doi.org/10.1161/CIRCULATIONAHA.106.671420
|
[5]
|
Ridker, P.M., Cushman, M., Stampfer, M.J., et al. (1997) Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men. New England Journal of Medicine, 336, 973-979.
https://doi.org/10.1056/NEJM199704033361401
|
[6]
|
Tjoelker, L.W., Wilder, C., Eberhardt, C., et al. (1995) Anti-Inflammatory Properties of a Platelet-Activating Factor Acetylhydrolase. Nature, 374, 549-553. https://doi.org/10.1038/374549a0
|
[7]
|
Morgan, E.N., Boyle, E.M., Yun, W., et al. (1999) Platelet-Activating Factor Acetylhydrolase Prevents Myocardial Ischemia-Reperfusion Injury. Circulation, 100, 365-368. https://doi.org/10.1161/01.CIR.100.suppl_2.II-365
|
[8]
|
Theilmeier, G., De Geest, B., Van Veldhoven, P.P., et al. (2000) HDL-Associated PAF-AH Reduces Endothelial Adhesiveness in apoE−/−Mice. The FASEB Journal, 14, 2032-2039. https://doi.org/10.1096/fj.99-1029com
|
[9]
|
Wang, W., Zhang, J., Wu, W., et al. (2011) Inhibition of Lipoprotein-Associated Phospholipase A2 Ameliorates Inflammation and Decreases Atherosclerotic Plaque Formation in ApoE-Deficient Mice. PLoS ONE, 6, e23425.
https://doi.org/10.1371/journal.pone.0023425
|
[10]
|
Wilensky, R.L., Shi, Y.I., Mohler, E.R., et al. (2008) Inhibition of Lipoprotein-Associated Phospholipase A2 Reduces Complex Coronary Atherosclerotic Plaque Development. Nature Medicine, 14, 1059-1066.
https://doi.org/10.1038/nm.1870
|
[11]
|
Packard, C.J., O’Reilly, D.S.J., Caslake, M.J., et al. (2000) Lipoprotein-Associated Phospholipase A2 as an Independent Predictor of Coronary Heart Disease. New England Journal of Medicine, 343, 1148-1155.
https://doi.org/10.1056/NEJM200010193431603
|
[12]
|
Hoffmann, M.M., Winkler, K., Renner, W., et al. (2009) Genetic Variants and Haplotypes of Lipoprotein Associated Phospholipase A2 and Their Influence on Cardiovascular Disease (The Ludwigshafen Risk and Cardiovascular Health Study). Journal of Thrombosis and Haemostasis, 7, 41-48. https://doi.org/10.1111/j.1538-7836.2008.03216.x
|
[13]
|
Hou, L., Chen, S., Yu, H., et al. (2009) Associations of PLA2G7 Gene Polymorphisms with Plasma Lipoprotein-Associated Phospholipase A2 Activity and Coronary Heart Disease in a Chinese Han Population: The Beijing Atherosclerosis Study. Human Genetics, 125, 11-20. https://doi.org/10.1007/s00439-008-0587-4
|
[14]
|
Abuzeid, A.M., Hawe, E., Humphries, S.E. and Talmud, P.J. (2003) Association between the Ala379Val Variant of the Lipoprotein Associated Phospholipase A2 and Risk of Myocardial Infarction in the North and South of Europe. Atherosclerosis, 168, 283-288. https://doi.org/10.1016/S0021-9150(03)00086-8
|
[15]
|
Li, L., Qi, L., Lv, N., et al. (2011) Association between Lipoprotein-Associated Phospholipase A2 Gene Polymorphism and Coronary Artery Disease in the Chinese Han Population. Annals of Human Genetics, 75, 605-611.
https://doi.org/10.1111/j.1469-1809.2011.00666.x
|
[16]
|
Yamada, Y., Ichihara, S., Fujimura, T., et al. (1998) Identification of the G994→T Missense Mutation in Exon 9 of the Plasma Platelet-Activating Factor Acetylhydrolase Gene as an Independent Risk Factor for Coronary Artery Disease in Japanese Men. Metabolism, 47, 177-181. https://doi.org/10.1016/S0026-0495(98)90216-5
|
[17]
|
Shimokata, K., Yamada, Y., Kondo, T., et al. (2004) Association of Gene Polymorphisms with Coronary Artery Disease in Individuals with or without Nonfamilial Hypercholesterolemia. Atherosclerosis, 172, 167-173.
https://doi.org/10.1016/j.atherosclerosis.2003.09.019
|
[18]
|
Yangsoo, J., Yoen, K.O., Jeong, K.S., et al. (2006) The Val279Phe Variant of the Lipoprotein-Associated Phospholipase A2 Gene Is Associated with Catalytic Activities and Cardiovascular Disease in Korean Men. Journal of Clinical Endocrinology & Metabolism, 91, 3521-3527. https://doi.org/10.1210/jc.2006-0116
|
[19]
|
Ewa, N., David, T., Jean-Luc, C., et al. (2004) Platelet-Activating Factor-Acetylhydrolase and PAF-Receptor Gene Haplotypes in Relation to Future Cardiovascular Event in Patients with Coronary Artery Disease. Human Molecular Genetics, 13, 1341-1351. https://doi.org/10.1093/hmg/ddh145
|
[20]
|
Liu, P.Y., Li, Y.H., Wu, H.L., et al. (2006) Platelet-Activating Factor Acetylhydrolase A379V (Exon 11) Gene Polymorphism Is an Independent and Functional Risk Factor for Premature Myocardial Infarction. Journal of Thrombosis and Haemostasis, 4, 1023-1028. https://doi.org/10.1111/j.1538-7836.2006.01895.x
|
[21]
|
Casas, J.P., Ninio, E., Panayiotou, A., et al. (2010) PLA2G7 Genotype, Lipoprotein-Associated Phospholipase A2 Activity, and Coronary Heart Disease Risk in 10494 Cases and 15624 Controls of European Ancestry. Circulation, 121, 2284-2293. https://doi.org/10.1161/CIRCULATIONAHA.109.923383
|
[22]
|
殷宇岗, 吕磊, 杨春. 老年高血压患者脂蛋白相关磷脂酶A2、胰高血糖素样肽-1、血清淀粉样蛋白A表达水平与冠状动脉病变的相关性[J]. 中华高血压杂志, 2020, 28(12): 1191-1194.
|
[23]
|
Wallentin, L., Held, C., Armstrong, P.W., et al. (2016) Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients with Stable Coronary Heart Disease. Journal of the American Heart Association, 5, e003407.
|
[24]
|
Kaur, C., Foulds, W.S. and Ling, E.A. (2008) Blood-Retinal Barrier in Hypoxic Ischaemic Conditions: Basic Concepts, Clinical Features and Management. Progress in Retinal & Eye Research, 27, 622-647.
https://doi.org/10.1016/j.preteyeres.2008.09.003
|
[25]
|
Hall, A.P. (2006) Review of the Pericyte during Angiogenesis and Its Role in Cancer and Diabetic Retinopathy. Toxicologic Pathology, 34, 763-775. https://doi.org/10.1080/01926230600936290
|
[26]
|
Camera, A., Hopps, E. and Caimi, G. (2007) Diabetic Microangiopathy: Physiopathological, Clinical and Therapeutic Aspects. Minerva Endocrinologica, 32, 209-229.
|
[27]
|
Moschos, M.M., Pantazis, P., Gatzioufas, Z., et al. (2016) Association between Platelet Activating Factor Acetylhydrolase and Diabetic Retinopathy: Does Inflammation Affect the Retinal Status? Prostaglandins & Other Lipid Mediators, 122, 69-72. https://doi.org/10.1016/j.prostaglandins.2016.01.001
|
[28]
|
李婷婷. Lp-PLA2与2型糖尿病肾脏疾病的相关性研究[D]: [硕士学位论文]. 南京: 南京医科大学, 2019.
|
[29]
|
武仅. 脂蛋白相关磷脂酶A2水平与2型糖尿病患者肾病分期的相关性分析[D]: [硕士学位论文]. 郑州: 郑州大学, 2019.
|
[30]
|
张伟亚, 卢宇, 张青青, 等. 脂蛋白相关磷脂酶A2和胱抑素C对糖尿病肾脏疾病早期诊断应用价值的研究[J]. 中国糖尿病杂志, 2021, 29(8): 601-605.
|
[31]
|
吴炎, 张睿, 黄冰, 廖淑萍. 糖尿病足患者血浆脂蛋白相关磷脂酶A2、D-二聚体和纤维蛋白原水平变化及临床意义[J]. 检验医学与临床, 2018, 15(14): 2175-2177.
|
[32]
|
Lehtinen, L., Vainio, P., Wikman, H., et al. (2017) PLA2G7 Associates with Hormone Receptor Negativity in Clinical Breast Cancer Samples and Regulates Epithelial-Mesenchymal Transition in Cultured Breast Cancer Cells. The Journal of Pathology: Clinical Research, 3, 123-138. https://doi.org/10.1002/cjp2.69
|
[33]
|
Stafforini, D.M. (2015) Diverse Functions of Plasma PAF-AH in Tumorigenesis. Enzymes, 38, 157-179.
https://doi.org/10.1016/bs.enz.2015.09.005
|
[34]
|
Vainio, P., Gupta, S., Ketola, K., et al. (2011) Arachidonic Acid Pathway Members PLA2G7, HPGD, EPHX2, and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate Cancer. The American Journal of Pathology, 178, 525-536. https://doi.org/10.1016/j.ajpath.2010.10.002
|
[35]
|
Vainio, P., Lehtinen, L., Mirtti, T., et al. (2011) Phospholipase PLA2G7, Associated with Aggressive Prostate Cancer, Promotes Prostate Cancer Cell Migration and Invasion and Is Inhibited by Statins. Oncotarget, 2, 1176.
https://doi.org/10.18632/oncotarget.397
|
[36]
|
Xu, C., Reichert, E.C., Nakano, T., et al. (2013) Deficiency of Phospholipase A2 Group 7 Decreases Intestinal Polyposis and Colon Tumorigenesis in Apc(Min/+) Mice. Cancer Research, 73, 2806-2816.
https://doi.org/10.1158/0008-5472.CAN-12-2374
|
[37]
|
Qu, H., Zhang, G., Pan, J., et al. (2021) Evaluation of Lipoprotein-Associated Phospholipase A2 as a Prognostic Biomarker in Chronic Kidney Disease. Clinical Laboratory, 67-68. https://doi.org/10.7754/Clin.Lab.2021.201114
|
[38]
|
穆妮热·约麦尔, 周志强, 周友栩, 吴成稳, 李飞, 梁晓丹, 康海涵. 脂蛋白相关磷脂酶A2水平与下肢动脉硬化闭塞症严重程度的相关性分析[J]. 中国临床新医学, 2021, 14(7): 705-709.
|
[39]
|
Grinspoon, S. (2018) Novel Mechanisms and Anti-Inflammatory Strategies to Reduce Cardiovascular Risk in Human Immunodeficiency Virus. Transactions of the American Clinical and Climatological Association, 129, 140-154.
|
[40]
|
Losche, W., Marshal, G.J., Apatzidou, D.A., et al. (2005) Lipoprotein-Associated Phospholipase A2 and Plasma Lipids in Patients with Destructive Periodontal Disease. Journal of Clinical Periodontology, 32, 640-644.
https://doi.org/10.1111/j.1600-051X.2005.00725.x
|
[41]
|
Beck, J.D., Elter, J.R., Heiss, G., et al. (2001) Relationship of Periodontal Disease to Carotid Artery Intima-Media Wall Thickness: The Atherosclerosis Risk in Communities (ARIC) Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 1816-1822. https://doi.org/10.1161/hq1101.097803
|
[42]
|
Colak, Y., Senates, E., Ozturk, O., et al. (2012) Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease. Metabolic Syndrome and Related Disorders, 10, 103-109.
https://doi.org/10.1089/met.2011.0111
|
[43]
|
Liu, Z., Li, H., Zheng, Y., et al. (2018) Association of Lipoprotein-Associated Phospholipase A2 with the Prevalence of Nonalcoholic Fatty Liver Disease: A Result from the APAC Study. Scientific Reports, 8, Article No. 10127.
https://doi.org/10.1038/s41598-018-28494-8
|
[44]
|
Hayek, J., Cervellati, I., Pecorelli, A. and Valacchi, G. (2017) Lactonase Activity and Lipoprotein-Phospholipase A2 as Possible Novel Serum Biomarkers for the Differential Diagnosis of Autism Spectrum Disorders and Rett Syndrome: Results from a Pilot Study. Oxidative Medicine and Cellular Longevity, 2017, Article ID: 5694058.
https://doi.org/10.1155/2017/5694058
|
[45]
|
Kheirandish-Gozal, L., Philby, M.F., Qiao, Z., et al. (2017) Endothelial Dysfunction in Children with Obstructive Sleep Apnea Is Associated with Elevated Lipoprotein-Associated Phospholipase A2 Plasma Activity Levels. Journal of the American Heart Association, 6, e004923. https://doi.org/10.1161/JAHA.116.004923
|
[46]
|
Fabris, M., Cifu, A., Pistis, C., et al. (2017) Exploring the Plasmatic Platelet-Activating Factor Acetylhydrolase Activity in Patients with Anti-Phospholipid Antibodies. Autoimmunity Highlights, 8, 5.
https://doi.org/10.1007/s13317-017-0092-7
|
[47]
|
Sodergren, A., Karp, K., Bengtsson, C., et al. (2015) Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis? BioMed Research International, 2015, Article ID: 673018. https://doi.org/10.1155/2015/673018
|
[48]
|
Acosta, S., Taimour, S., Gottsater, A., et al. (2017) Lp-PLA2 Activity and Mass for Prediction of Incident Abdominal Aortic Aneurysms: A Prospective Longitudinal Cohort Study. Atherosclerosis, 262, 14-18.
https://doi.org/10.1016/j.atherosclerosis.2017.04.014
|
[49]
|
Epps, K.C. and Wilensky, R.L. (2011) Lp-PLA2—A Novel Risk Factor for High-Risk Coronary and Carotid Artery Disease. Journal of Internal Medicine, 269, 94-106. https://doi.org/10.1111/j.1365-2796.2010.02297.x
|
[50]
|
蒋洋波, 王权, 季敏, 姜文, 郑锡凤, 王文玥, 高伟. 血清可溶性CD40配体、脂蛋白相关的磷脂酶A2水平与老年急性脑梗死的相关性[J/OL]. 武汉大学学报(医学版), 2021, 1-5[2021-11-12].
|